Select Page

Month: August 2017

Buprenorphine for PCPs: Ten Elements of Success

The California Health Care Foundation distributed a report based on a review of the current literature related to buprenorphine, with a focus on identifying best practices in place or emerging around the integration of MAT into primary care setting, as well as interviews conducted with 18 experts in the field. Fact...

Read More

Enhancing ERAS with Multimodal Pain Mgmt

Perioperative quality and service is an increasing area of focus for hospitals. Enhanced recovery after surgery (ERAS) protocols are important processes that many hospitals are implementing to help improve perioperative care—with significant benefits for both healthcare facilities and patients. For some hospitals, multimodal approaches to pain management are becoming the cornerstone of ERAS programs. Traditionally, postoperative pain has primarily been treated using opioids. Use of opioids as the “mainstay” of pain management can result in psychological addiction and adverse effects, such as nausea and vomiting, sedation, dizziness, constipation and respiratory depression—all of which may delay patient discharge. Multimodal pain...

Read More

Updated Prior Approval Criteria for Opioids

Beginning Aug. 27, NCTracks will require prior approval for opioid analgesic doses exceeding 120 mg of morphine equivalents per day, for greater than a 14-day supply of any opioid and for any non-preferred opioid product for Medicaid and Health Choice beneficiaries. Requirement Details on Page...

Read More

Patient Counseling: How to Start the Conversation

Pharmacists play an important role as leaders in preventing the misuse and potential overdose of opioid medication. Community pharmacist and business owner, Cathy Huie, PharmD, FIACP, CPP, shares ways to help pharmacists feel more comfortable accessing risks and providing counseling and education in ensuring patient safety when using opioid medication. This video is a project of the Governor’s Institute supported by the NC Department of Heath and Human Services, Division of Mental Health, Developmental Disabilities and Substance Abuse Services with funding from SAMHSA, Strategic Prevention Framework for Prescription Drugs (CFDA #93.243). Collaboration and content development provided by the North Carolina...

Read More

ASAM’s Position on 42 CFR Part 2

In the wake of the introduction of the Overdose Prevention and Patient Safety (OPPS) Act, a bill that would amend the federal statute underlying the addiction treatment privacy regulations known as 42 CFR Part 2 (“Part 2”), ASAM has released a position statement. It was decided that the barriers that Part 2 currently presents to coordinated, safe, and high-quality medical care cause significant harm, and that thoughtful changes to the law are necessary to mitigate this harm while protecting patients’ privacy. Accordingly, ASAM joined other provider associations, patient groups, and health plans to support the OPPS Act, which would...

Read More
  • 1
  • 2